Lipoprotein(a) and Aspirin: A New Perspective on Aspirin for an Emerging Risk Factor- Dr Nithin Rao Voruganti Written By Dr. Nithin Rao Voruganti14 Aug 2026 12:00 PM ISTPatient Profile* A 52-year-old Indian man, an IT professional from Mumbai, presents for a routine preventive health evaluation. He is a non-smoker...
Beta Blocker Interruption Causes Heart Rate Rebound and Worse CV Outcomes in Post-MI Patients: New Pre-Specified Analysis of ABYSS Trial Written By Prem Aggarwal11 Aug 2026 10:28 AM ISTBeta-blocker interruption causes significant heart rate rebound and increased CV risk in patients with elevated baseline heart rate; while heart rate...
Troponin Variability After CABG May Create Diagnostic Uncertainty, Reveals Research Written By Medha Baranwal10 Aug 2026 9:30 AM ISTSwitzerland: After uneventful coronary artery bypass graft (CABG) surgery, elevations in cardiac troponins are common. According to a new study,...
New treatment may reduce risk of heart failure after heart attack, finds research Written By Dr. Kamal Kant Kohli5 Aug 2026 8:45 PM ISTMany people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala...
Cardiovascular Risk Management in T2D with established ASCVD: Current Evidence for Dapagliflozin and Sitagliptin-Dr Piyas Gargari Written By Dr. Piyas Gargari5 Aug 2026 10:43 AM ISTType 2 diabetes (T2D) frequently presents with cardiovascular complications already established, with cardiovascular diseases (CVD) accounting for...
Low Skeletal Muscle Density on Coronary CT Linked to Higher Heart Attack and Mortality Risk: Study Written By Medha Baranwal14 July 2026 9:00 PM ISTUK: A machine learning analysis of coronary CT angiography (CCTA) scans has found that skeletal muscle quality may provide important information about...
Merck Marks Beta Blocker Month: Revisiting a Landmark Discovery & Spotlight on Bisoprolol Written By Dr. Kamal Kant Kohli30 Jun 2026 11:57 AM ISTMerck is commemorating Beta Blocker Month in June by celebrating the discovery of beta-blockers, their lasting impact on cardiovascular care, and...
IV Atorvastatin During MI Reduces Heart Damage More Than Oral Loading Dose: Study Written By Dr. Kamal Kant Kohli24 Jun 2026 12:00 PM ISTReducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, even when the blocked...
Targeted Primary Prevention with Low-Dose Aspirin in Chronic Kidney Disease: The Predictive Role of Lipoprotein(a) Bio-Stratification- Dr Pradeep Kumar Meena Written By Dr Pradeep Kumar Meena17 Jun 2026 12:00 PM ISTA 2025 analysis of the Chronic Renal Insufficiency Cohort (CRIC) published in JACC: Advances provides a practical solution to the long-standing...
Findings from the first randomised trial assessing RNA therapy in heart failure Written By Dr. Kamal Kant Kohli15 Jun 2026 10:30 PM ISTResults from the first randomised trial evaluating microRNA inhibition in heart failure were presented today at Heart Failure 2026, the annual...
Biolimus-Eluting Stents Match Efficacy and Improve Long-Term Safety with conventional SES: Meta analysis Written By Dr Riya Dave3 Jun 2026 9:30 AM ISTA systematic review and meta-analysis on randomized controlled trials have shown that biolimus-eluting stents (BES) offer comparable long-term...
